Global Distribution of Tropical Diseases

Communities of practice Partnerships

South-South Initiative for Tropical Diseases Research
Initiative to Strengthen Health Research Capacity in Africa (ISHReCA)
Malaria Eradication Research Agenda (malERA)
Research Partnerships for Neglected Diseases of Poverty

Leprosy  Click for RSS

Leprosy is occasionally known as Hansen’s disease, after Armauer Hansen, the Norwegian physician who first identified the microorganism which causes the disease. Known and dreaded since biblical times because of the severe deformities that can occur, it was considered incurable until as recently as the 1940s.

Review Articles

2 Jun 2010

Do the poor benefit from infectious disease programmes?

When interventions are planned, insufficient thought is given as to whether the poorest and most vulnerable members of society will benefit, according to the findings of a new review of the evidence. The reviewers call for more research to assess which infectious disease programmes benefit the poor and to identify the mechanisms that determine “pro-poor effectiveness”.
Source: Journal
Read... | PDF

29 Jan 2010

World Leprosy Day – the battle has yet to be won

There are still a quarter of a million new cases every year. A leading specialist says that leprosy research – but not leprosy – has been “eliminated”.

More Leprosy Review Articles >


18 Nov 2010

Reactions to the WHO report on neglected tropical diseases

What is the place for research in global efforts to control neglected tropical diseases?

28 May 2010

Public searches now possible of database of global R&D funding

Access to data from the G-FINDER survey will help funders and product developers better understand where funding gaps lie and how their investments fit into the global picture.
Source: George Institute

More Leprosy News >

Editorial Opinions

24 Feb 2011

Funding research into the infectious diseases of poverty: what happens now?

The latest G-FINDER report says that funding for basic scientific research has increased but finances available for product development have fallen. How can funders determine where the greatest needs lie and work more closely together?

More Leprosy Editorial Opinions >

Research Articles

20 May 2010

New drugs still lacking for the infectious diseases of poverty

So far in the 21st century (and with the exception of malaria and AIDS), only four new products have become available for treating or preventing infections in poor communities.
Source: PLoS ONE
Read... | PDF External link

10 Jul 2009

Disseminated bacille Calmette–Guérin disease in HIV-infected South African infants

BCG vaccination is still widely given in many parts of the world but a study confirms that its use may harm those children who are HIV infected.
Source: Bulletin of the World Health Organization
PubMed Record External link | Read... | PDF External link

More Leprosy Research Articles >


18 Dec 2009

Neglected disease research & development: new times, new trends

The global budget for research into the infectious diseases of poverty is little changed and AIDS continues to receive a disproportionately large share of the total. But India and Brazil are emerging as key players, particular for the more neglected diseases.
Source: George Institute
Read... | PDF External link

8 May 2009

Improving Effectiveness and Outcomes for the Poor in Health, Nutrition, and Population

The World Bank evaluates its support for health, population and nutrition programmes... and reaches some surprising conclusions.
Source: World Bank
Read... | PDF External link

More Leprosy Reports >

Sign in



Register for free
Forgot your password?

Is your organisation working against the infectious diseases of poverty?